Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study-Reference-Cited by-同舟云学术

Caspofungin first-line therapy for invasive aspergillosis in allogeneic hematopoietic stem cell transplant patients: an European Organisation for Research and Treatment of Cancer study

Published:2010-01-11 Issue:7 Volume:45 Page:1227-1233
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Herbrecht R, ,Maertens J,Baila L,Aoun M,Heinz W,Martino R,Schwartz S,Ullmann A J,Meert L,Paesmans M,Marchetti O,Akan H,Ameye L,Shivaprakash M,Viscoli C

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/bmt2009334.pdf

Reference26 articles.

1. Marr K, Carter RA, Boeckh M, Martin P, Corey L . Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors. Blood 2002; 100: 4358–4366.

2. Martino R, Subira M . Invasive fungal infections in hematology: new trends. Ann Hematol 2002; 81: 233–243.

3. Ribaud P, Chastang C, Latgé JP, Baffroy-Lafitte L, Parquet N, Devergie A et al. Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation. Clin Infect Dis 1999; 28: 322–330.

4. Nivoix Y, Velten M, Letscher-Bru V, Moghaddam A, Natarajan-Amé S, Fohrer C et al. Factors associated with overall and attributable mortality in invasive aspergillosis. Clin Infect Dis 2008; 47: 1176–1184.

5. Marr K, Carter RA, Crippa F, Wald A, Corey L . Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients. Clin Infect Dis 2002; 34: 909–917.

Cited by 132 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The efficacy and safety analysis of oral isavuconazole therapy of invasive pulmonary aspergillosis;2024-06-25

2. How do I manage refractory invasive pulmonary aspergillosis;Clinical Microbiology and Infection;2024-06

3. Efficacy and safety of caspofungin for the treatment of invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease;Journal of International Medical Research;2024-03

4. Safety and efficacy of non-reduced use of caspofungin in patients with Child–Pugh B or C cirrhosis: a real-world study;Infection;2024-01-24

5. Antifungal Prophylaxis in the Era of Targeted Chemotherapy for Acute Myelogenous Leukemia;Current Fungal Infection Reports;2023-07-27